Barry E. Greene
2019 - Alnylam Pharmaceuticals
In 2019, Barry E. Greene earned a total compensation of $3.1M as Former President at Alnylam Pharmaceuticals, a 4% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $385,323 |
|---|---|
| Option Awards | $1,654,494 |
| Salary | $596,820 |
| Stock Awards | $460,360 |
| Other | $21,367 |
| Total | $3,118,364 |
Greene received $1.7M in option awards, accounting for 53% of the total pay in 2019.
Greene also received $385.3K in non-equity incentive plan, $596.8K in salary, $460.4K in stock awards and $21.4K in other compensation.
Rankings
In 2019, Barry E. Greene's compensation ranked 3,927th out of 13,971 executives tracked by ExecPay. In other words, Greene earned more than 71.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,927 out of 13,971 | 72nd |
Division Manufacturing | 1,419 out of 5,695 | 75th |
Major group Chemicals And Allied Products | 499 out of 2,194 | 77th |
Industry group Drugs | 422 out of 1,880 | 78th |
Industry Pharmaceutical Preparations | 320 out of 1,392 | 77th |
Source: SEC filing on April 2, 2021.
Greene's colleagues
We found five more compensation records of executives who worked with Barry E. Greene at Alnylam Pharmaceuticals in 2019.
2019
John Maraganore
Alnylam Pharmaceuticals
Chief Executive Officer
2019
Jeffrey Poulton
Alnylam Pharmaceuticals
Chief Financial Officer
2019
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2019
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2019
Laurie Keating
Alnylam Pharmaceuticals